Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response

English version České info

The pattern recognition receptor RIG-I is critical for Type-I interferon production. However, the global regulation of RIG-I signaling is only partially understood. Using a human genome-wide RNAi-screen, we identified 226 novel regulatory proteins of RIG-I mediated interferon-β production. Furthermore, the screen identified a metabolic pathway that synthesizes the inositol pyrophosphate 1-IP7 as a previously unrecognized positive regulator of interferon production. Detailed genetic and biochemical experiments demonstrated that the kinase activities of IPPK, PPIP5K1 and PPIP5K2 (which convert IP5 to1-IP7) were critical for both interferon induction, and the control of cellular infection by Sendai and influenza A viruses. Conversely, ectopically expressed inositol pyrophosphate-hydrolases DIPPs attenuated interferon transcription. Mechanistic experiments in intact cells revealed that the expression of IPPK, PPIP5K1 and PPIP5K2 was needed for the phosphorylation and activation of IRF3, a transcription factor for interferon. The addition of purified individual inositol pyrophosphates to a cell free reconstituted RIG-I signaling assay further identified 1-IP7 as an essential component required for IRF3 activation. The inositol pyrophosphate may act by β-phosphoryl transfer, since its action was not recapitulated by a synthetic phosphonoacetate analogue of 1-IP7. This study thus identified several novel regulators of RIG-I, and a new role for inositol pyrophosphates in augmenting innate immune responses to viral infection that may have therapeutic applications.

Vyšlo v časopise: Human Genome-Wide RNAi Screen Identifies an Essential Role for Inositol Pyrophosphates in Type-I Interferon Response. PLoS Pathog 10(2): e32767. doi:10.1371/journal.ppat.1003981
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1003981

Souhrn

Zdroje

1. KumarH, KawaiT, AkiraS (2009) Pathogen recognition in the innate immune response. Biochem J 420: 1–16.

2. LiuSY, SanchezDJ, ChengG (2011) New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol 23: 57–64.

3. YoneyamaM, FujitaT (2010) Recognition of viral nucleic acids in innate immunity. Rev Med Virol 20: 4–22.

4. BelgnaouiSM, PazS, HiscottJ (2011) Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter. Curr Opin Immunol 23: 564–572.

5. RamosHJ, GaleMJr (2011) RIG-I like receptors and their signaling crosstalk in the regulation of antiviral immunity. Curr Opin Virol 1: 167–176.

6. SethRB, SunL, ChenZJ (2006) Antiviral innate immunity pathways. Cell Res 16: 141–147.

7. YoneyamaM, KikuchiM, NatsukawaT, ShinobuN, ImaizumiT, et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730–737.

8. HiscottJ, PithaP, GeninP, NguyenH, HeylbroeckC, et al. (1999) Triggering the interferon response: the role of IRF-3 transcription factor. J Interferon Cytokine Res 19: 1–13.

9. LinR, MamaneY, HiscottJ (1999) Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol Cell Biol 19: 2465–2474.

10. SuharaW, YoneyamaM, IwamuraT, YoshimuraS, TamuraK, et al. (2000) Analyses of virus-induced homomeric and heteromeric protein associations between IRF-3 and coactivator CBP/p300. J Biochem 128: 301–307.

11. BordenEC, SenGC, UzeG, SilvermanRH, RansohoffRM, et al. (2007) Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 6: 975–990.

12. GackMU, ShinYC, JooCH, UranoT, LiangC, et al. (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446: 916–920.

13. JiangX, KinchLN, BrautigamCA, ChenX, DuF, et al. (2012) Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 36: 959–973.

14. LiuHM, LooYM, HornerSM, ZornetzerGA, KatzeMG, et al. (2012) The mitochondrial targeting chaperone 14-3-3epsilon regulates a RIG-I translocon that mediates membrane association and innate antiviral immunity. Cell Host Microbe 11: 528–537.

15. OshiumiH, MiyashitaM, InoueN, OkabeM, MatsumotoM, et al. (2010) The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 8: 496–509.

16. SaitohT, Tun-KyiA, RyoA, YamamotoM, FinnG, et al. (2006) Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol 7: 598–605.

17. VersteegGA, RajsbaumR, Sanchez-AparicioMT, MaestreAM, ValdiviezoJ, et al. (2013) The E3-ligase TRIM family of proteins regulates signaling pathways triggered by innate immune pattern-recognition receptors. Immunity 38: 384–398.

18. WiesE, WangMK, MaharajNP, ChenK, ZhouS, et al. (2013) Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 38: 437–449.

19. MunkC, SommerAF, KonigR (2011) Systems-biology approaches to discover anti-viral effectors of the human innate immune response. Viruses 3: 1112–1130.

20. GardyJL, LynnDJ, BrinkmanFS, HancockRE (2009) Enabling a systems biology approach to immunology: focus on innate immunity. Trends Immunol 30: 249–262.

21. ShapiraSD, Gat-ViksI, ShumBO, DricotA, de GraceMM, et al. (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139: 1255–1267.

22. SutharMS, BrassilMM, BlahnikG, McMillanA, RamosHJ, et al. (2013) A systems biology approach reveals that tissue tropism to West Nile virus is regulated by antiviral genes and innate immune cellular processes. PLoS Pathog 9: e1003168.

23. MennitiFS, MillerRN, PutneyJWJr, ShearsSB (1993) Turnover of inositol polyphosphate pyrophosphates in pancreatoma cells. J Biol Chem 268: 3850–3856.

24. StephensL, RadenbergT, ThielU, VogelG, KhooKH, et al. (1993) The detection, purification, structural characterization, and metabolism of diphosphoinositol pentakisphosphate(s) and bisdiphosphoinositol tetrakisphosphate(s). J Biol Chem 268: 4009–4015.

25. TsuiMM, YorkJD (2010) Roles of inositol phosphates and inositol pyrophosphates in development, cell signaling and nuclear processes. Adv Enzyme Regul 50: 324–337.

26. JadavRS, ChanduriMV, SenguptaS, BhandariR (2013) Inositol pyrophosphate synthesis by inositol hexakisphosphate kinase 1 is required for homologous recombination repair. J Biol Chem 288: 3312–3321.

27. KoldobskiyMA, ChakrabortyA, WernerJKJr, SnowmanAM, JuluriKR, et al. (2010) p53-mediated apoptosis requires inositol hexakisphosphate kinase-2. Proc Natl Acad Sci U S A 107: 20947–20951.

28. MorrisonBH, BauerJA, KalvakolanuDV, LindnerDJ (2001) Inositol hexakisphosphate kinase 2 mediates growth suppressive and apoptotic effects of interferon-beta in ovarian carcinoma cells. J Biol Chem 276: 24965–24970.

29. IlliesC, GromadaJ, FiumeR, LeibigerB, YuJ, et al. (2007) Requirement of inositol pyrophosphates for full exocytotic capacity in pancreatic beta cells. Science 318: 1299–1302.

30. ChakrabortyA, KoldobskiyMA, BelloNT, MaxwellM, PotterJJ, et al. (2010) Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain. Cell 143: 897–910.

31. PrasadA, JiaY, ChakrabortyA, LiY, JainSK, et al. (2011) Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling. Nat Immunol 12: 752–760.

32. BozymRA, Delorme-AxfordE, HarrisK, MoroskyS, IkizlerM, et al. (2012) Focal adhesion kinase is a component of antiviral RIG-I-like receptor signaling. Cell Host Microbe 11: 153–166.

33. KokKH, LuiPY, NgMH, SiuKL, AuSW, et al. (2011) The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 9: 299–309.

34. ZhuJ, SmithK, HsiehPN, MburuYK, ChattopadhyayS, et al. (2010) High-throughput screening for TLR3-IFN regulatory factor 3 signaling pathway modulators identifies several antipsychotic drugs as TLR inhibitors. J Immunol 184: 5768–5776.

35. LiY, XieJ, WuS, XiaJ, ZhangP, et al. (2013) Protein kinase regulated by dsRNA downregulates the interferon production in dengue virus- and dsRNA-stimulated human lung epithelial cells. PLoS One 8: e55108.

36. YangK, ShiHX, LiuXY, ShanYF, WeiB, et al. (2009) TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J Immunol 182: 3782–3792.

37. BolenCR, RobekMD, BrodskyL, SchulzV, LimJK, et al. (2013) The blood transcriptional signature of chronic hepatitis C virus is consistent with an ongoing interferon-mediated antiviral response. J Interferon Cytokine Res 33: 15–23.

38. CaskeyM, LefebvreF, Filali-MouhimA, CameronMJ, GouletJP, et al. (2011) Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med 208: 2357–2366.

39. IndraccoloS, PfefferU, MinuzzoS, EspositoG, RoniV, et al. (2007) Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol 178: 1122–1135.

40. LeeSM, ChanRW, GardyJL, LoCK, SihoeAD, et al. (2010) Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro. Respir Res 11: 147.

41. FennerBJ, ScannellM, PrehnJH (2010) Expanding the substantial interactome of NEMO using protein microarrays. PLoS One 5: e8799.

42. BelgnaouiSM, PazS, SamuelS, GouletML, SunQ, et al. (2012) Linear ubiquitination of NEMO negatively regulates the interferon antiviral response through disruption of the MAVS-TRAF3 complex. Cell Host Microbe 12: 211–222.

43. ShearsSB, GokhaleNA, WangH, ZarembaA (2011) Diphosphoinositol polyphosphates: what are the mechanisms? Adv Enzyme Regul 51: 13–25.

44. BarkerCJ, IlliesC, GaboardiGC, BerggrenPO (2009) Inositol pyrophosphates: structure, enzymology and function. Cell Mol Life Sci 66: 3851–3871.

45. BennettM, OnneboSM, AzevedoC, SaiardiA (2006) Inositol pyrophosphates: metabolism and signaling. Cell Mol Life Sci 63: 552–564.

46. ChoiJH, WilliamsJ, ChoJ, FalckJR, ShearsSB (2007) Purification, sequencing, and molecular identification of a mammalian PP-InsP5 kinase that is activated when cells are exposed to hyperosmotic stress. J Biol Chem 282: 30763–30775.

47. FridyPC, OttoJC, DollinsDE, YorkJD (2007) Cloning and characterization of two human VIP1-like inositol hexakisphosphate and diphosphoinositol pentakisphosphate kinases. J Biol Chem 282: 30754–30762.

48. MuluguS, BaiW, FridyPC, BastidasRJ, OttoJC, et al. (2007) A conserved family of enzymes that phosphorylate inositol hexakisphosphate. Science 316: 106–109.

49. WundenbergT, MayrGW (2012) Synthesis and biological actions of diphosphoinositol phosphates (inositol pyrophosphates), regulators of cell homeostasis. Biol Chem 393: 979–998.

50. BhandariR, JuluriKR, ResnickAC, SnyderSH (2008) Gene deletion of inositol hexakisphosphate kinase 1 reveals inositol pyrophosphate regulation of insulin secretion, growth, and spermiogenesis. Proc Natl Acad Sci U S A 105: 2349–2353.

51. SzijgyartoZ, GaredewA, AzevedoC, SaiardiA (2011) Influence of inositol pyrophosphates on cellular energy dynamics. Science 334: 802–805.

52. RehwinkelJ, TanCP, GoubauD, SchulzO, PichlmairA, et al. (2010) RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140: 397–408.

53. PadmanabhanU, DollinsDE, FridyPC, YorkJD, DownesCP (2009) Characterization of a selective inhibitor of inositol hexakisphosphate kinases: use in defining biological roles and metabolic relationships of inositol pyrophosphates. J Biol Chem 284: 10571–10582.

54. KilariRS, WeaverJD, ShearsSB, SafranyST (2013) Understanding inositol pyrophosphate metabolism and function: kinetic characterization of the DIPPs. FEBS Lett 587: 3464–3470.

55. LonettiA, SzijgyartoZ, BoschD, LossO, AzevedoC, et al. (2011) Identification of an evolutionarily conserved family of inorganic polyphosphate endopolyphosphatases. J Biol Chem 286: 31966–31974.

56. ZengW, XuM, LiuS, SunL, ChenZJ (2009) Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol Cell 36: 315–325.

57. WeaverJD, WangH, ShearsSB (2012) The kinetic properties of a human PPIP5K reveal that its kinase activities are protected against the consequences of a deteriorating cellular bioenergetic environment. Biosci Rep 33 (2) pii: e00022.

58. AzevedoC, BurtonA, Ruiz-MateosE, MarshM, SaiardiA (2009) Inositol pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag release. Proc Natl Acad Sci U S A 106: 21161–21166.

59. BhandariR, SaiardiA, AhmadibeniY, SnowmanAM, ResnickAC, et al. (2007) Protein pyrophosphorylation by inositol pyrophosphates is a posttranslational event. Proc Natl Acad Sci U S A 104: 15305–15310.

60. RileyAM, WangH, WeaverJD, ShearsSB, PotterBV (2012) First synthetic analogues of diphosphoinositol polyphosphates: interaction with PP-InsP5 kinase. Chem Commun (Camb) 48: 11292–11294.

61. JinC, FlavellRA (2013) Innate sensors of pathogen and stress: linking inflammation to obesity. J Allergy Clin Immunol 132: 287–294.

62. WangH, FalckJR, HallTM, ShearsSB (2012) Structural basis for an inositol pyrophosphate kinase surmounting phosphate crowding. Nat Chem Biol 8: 111–116.

63. ChakrabortyA, KimS, SnyderSH (2011) Inositol pyrophosphates as mammalian cell signals. Sci Signal 4: re1.

64. LeeYS, MuluguS, YorkJD, O'SheaEK (2007) Regulation of a cyclin-CDK-CDK inhibitor complex by inositol pyrophosphates. Science 316: 109–112.

65. SaiardiA, BhandariR, ResnickAC, SnowmanAM, SnyderSH (2004) Phosphorylation of proteins by inositol pyrophosphates. Science 306: 2101–2105.

66. KawasakiT, TakemuraN, StandleyDM, AkiraS, KawaiT (2013) The second messenger phosphatidylinositol-5-phosphate facilitates antiviral innate immune signaling. Cell Host Microbe 14: 148–158.

67. RieberN, KnappB, EilsR, KaderaliL (2009) RNAither, an automated pipeline for the statistical analysis of high-throughput RNAi screens. Bioinformatics 25: 678–679.

68. ManicassamyB, ManicassamyS, Belicha-VillanuevaA, PisanelliG, PulendranB, et al. (2010) Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc Natl Acad Sci U S A 107: 11531–11536.

69. IwamuraT, YoneyamaM, YamaguchiK, SuharaW, MoriW, et al. (2001) Induction of IRF-3/-7 kinase and NF-kappaB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6: 375–388.

70. LinR, HeylbroeckC, PithaPM, HiscottJ (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18: 2986–2996.

71. LossO, AzevedoC, SzijgyartoZ, BoschD, SaiardiA (2011) Preparation of quality inositol pyrophosphates. J Vis Exp e3027.

72. HoenigM, LeeRJ, FergusonDC (1989) A microtiter plate assay for inorganic phosphate. J Biochem Biophys Methods 19: 249–251.